Jake Lewis

Jake Lewis serves as a Contracting Officer Representative (COR) responsible for ensuring contractual compliance and performance oversight across federal acquisitions in the biological products manufacturing sector. In this role, he acts as the primary liaison between the government and contractors, monitoring deliverables, assessing technical performance, and facilitating contract modifications to meet mission-critical needs. His work directly supports the agency’s procurement mission by ensuring that high-stakes biological product contracts are executed with precision, accountability, and adherence to FAR regulations. He typically handles complex, technical acquisitions involving manufacturing, quality control, and supply chain assurance for non-diagnostic biological products. While specific contractor names are not available, Lewis maintains consistent working relationships with manufacturers and suppliers qualified to produce sterile, regulated biological substances under cGMP standards. His procurement patterns reflect collaboration with firms possessing robust quality systems, validated production processes, and established regulatory compliance histories. He engages with vendors through structured performance evaluations, periodic site visits, and formal contract administration procedures to ensure adherence to technical specifications and delivery timelines. Lewis demonstrates a strong preference for open competition, with 83.3% of his acquisitions conducted without set-asides, reflecting a focus on technical capability over socioeconomic categorization. However, he actively supports small business participation, with 16.7% of his awards designated as Total Small Business Set-Asides under FAR 19.5, indicating a measured but intentional commitment to expanding opportunities for qualified small manufacturers in this specialized domain. His procurement expertise is narrowly focused on NAICS 325414 — Biological Product (except Diagnostic) Manufacturing — encompassing the acquisition of vaccines, therapeutic proteins, and other biologics produced under strict FDA oversight. He specializes in procuring complex, regulated goods requiring validated manufacturing environments, cold chain logistics, and extensive documentation of batch records and quality control protocols, demonstrating deep technical fluency in biopharmaceutical supply chain requirements.